Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

NCT00115245

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Los Angeles, California, United States

Pasadena, California, United States

San Francisco, California, United States

Miami, Florida, United States

View all 15 locations

View Trial Details

Completed

Transient Elastography in Autoimmune Hepatitis

NCT01905254

Conditions: Autoimmune Diseases, Digestive System Diseases, Fibrosis, +8 more
Locations: Dept of Gastroenterology and Hepatology, University Medical Center Hamburg Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany

View Trial Details

Completed

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

NCT01783678

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +27 more
Locations: Darlinghurst, New South Wales, Australia

Sydney, New South Wales, Australia

Melbourne, Victoria, Australia

Parkville, Victoria, Australia

View all 24 locations

View Trial Details

Completed

Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)

NCT00704717

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)

NCT00727259

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

NCT01508156

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)

NCT01852604

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations: Not specified

View Trial Details

Completed

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

NCT01011166

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

NCT01464827

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Site Reference ID/Investigator# 57583 Birmingham, Alabama, United States

Site Reference ID/Investigator# 55530 Birmingham, Alabama, United States

Site Reference ID/Investigator# 55385 Dothan, Alabama, United States

Site Reference ID/Investigator# 55500 Phoenix, Arizona, United States

View all 97 locations

View Trial Details

Completed

Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

NCT00828269

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details